ArticleCancer medicine2024

Combined immune checkpoint inhibition with durvalumab and tremelimumab with and without radiofrequency ablation in patients with advanced biliary tract carcinoma.

Cecilia Monge et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.